These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child. Probst V; Evain S; Gournay V; Marie A; Schott JJ; Boisseau P; LE Marec H J Cardiovasc Electrophysiol; 2006 Jan; 17(1):97-100. PubMed ID: 16426410 [TBL] [Abstract][Full Text] [Related]
7. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome]. Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032 [TBL] [Abstract][Full Text] [Related]
8. Gene symbol: SCN5A. Crotti L; Ferrandi C; Insolia R; Pedrazzini M; Tosin L; Veia A; Turco A; De Ferrari GM; Schwartz PJ Hum Genet; 2007 Feb; 120(6):911-2. PubMed ID: 17438607 [No Abstract] [Full Text] [Related]
10. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A: Hong K; Berruezo-Sanchez A; Poungvarin N; Oliva A; Vatta M; Brugada J; Brugada P; Towbin JA; Dumaine R; Piñero-Galvez C; Antzelevitch C; Brugada R J Cardiovasc Electrophysiol; 2004 Jan; 15(1):64-9. PubMed ID: 15028074 [TBL] [Abstract][Full Text] [Related]
12. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel. Surber R; Hensellek S; Prochnau D; Werner GS; Benndorf K; Figulla HR; Zimmer T Cardiovasc Res; 2008 Mar; 77(4):740-8. PubMed ID: 18065446 [TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs. Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619 [TBL] [Abstract][Full Text] [Related]
14. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation. Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786 [TBL] [Abstract][Full Text] [Related]
16. Gender difference and drug challenge in Brugada syndrome. Shimizu W J Cardiovasc Electrophysiol; 2004 Jan; 15(1):70-1. PubMed ID: 15028075 [No Abstract] [Full Text] [Related]
17. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. Beaufort-Krol GC; van den Berg MP; Wilde AA; van Tintelen JP; Viersma JW; Bezzina CR; Bink-Boelkens MT J Am Coll Cardiol; 2005 Jul; 46(2):331-7. PubMed ID: 16022964 [TBL] [Abstract][Full Text] [Related]
18. Linkage analyses and SCN5A mutations screening in five sudden unexplained death syndrome (Lai-tai) families. Sangwatanaroj S; Yanatasneejit P; Sunsaneewitayakul B; Sitthisook S J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S54-61. PubMed ID: 12188452 [TBL] [Abstract][Full Text] [Related]
19. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. Makiyama T; Akao M; Shizuta S; Doi T; Nishiyama K; Oka Y; Ohno S; Nishio Y; Tsuji K; Itoh H; Kimura T; Kita T; Horie M J Am Coll Cardiol; 2008 Oct; 52(16):1326-34. PubMed ID: 18929244 [TBL] [Abstract][Full Text] [Related]
20. Gene symbol: LMNA. Arbustini E; Pasotti M; Pilotto A; Diegoli M; Brega A; Disabella E; Grasso M; Marziliano N Hum Genet; 2007 Feb; 120(6):910. PubMed ID: 17438628 [No Abstract] [Full Text] [Related] [Next] [New Search]